Preoperative detection of extraprostatic tumor extension in patients with primary prostate cancer utilizing [68Ga]Ga-PSMA-11 PET/MRI
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Preoperative detection of extraprostatic tumor extension in patients with primary prostate cancer utilizing [68Ga]Ga-PSMA-11 PET/MRI ; volume:15 ; number:1 ; day:12 ; month:12 ; year:2024 ; pages:1-12 ; date:12.2024
Insights into imaging ; 15, Heft 1 (12.12.2024), 1-12, 12.2024
- Urheber
-
Spielvogel, Clemens P.
Ning, Jing
Kluge, Kilian
Haberl, David
Wasinger, Gabriel
Yu, Josef
Einspieler, Holger
Papp, Laszlo
Grubmüller, Bernhard
Shariat, Shahrokh F.
Baltzer, Pascal A. T.
Clauser, Paola
Hartenbach, Markus
Kenner, Lukas
Hacker, Marcus
Haug, Alexander R.
Rasul, Sazan
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13244-024-01876-5
- URN
-
urn:nbn:de:101:1-2502242123060.432500596691
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Spielvogel, Clemens P.
- Ning, Jing
- Kluge, Kilian
- Haberl, David
- Wasinger, Gabriel
- Yu, Josef
- Einspieler, Holger
- Papp, Laszlo
- Grubmüller, Bernhard
- Shariat, Shahrokh F.
- Baltzer, Pascal A. T.
- Clauser, Paola
- Hartenbach, Markus
- Kenner, Lukas
- Hacker, Marcus
- Haug, Alexander R.
- Rasul, Sazan
- SpringerLink (Online service)
Ähnliche Objekte (12)
Gross tumor volume delineation in primary prostate cancer on 18F-PSMA-1007 PET/MRI and 68Ga-PSMA-11 PET/MRI
Evaluation of prostatic lesions by simultaneous [68Ga]Ga-PSMA-11 PET/MRI
Recurrent prostate cancer: combined role for MRI and PSMA-PET in 68Ga-PSMA-11 PET/MRI
68Ga-PSMA-11 PET/MRI: determining ideal acquisition times to reduce noise and increase image quality
Optimal MRI sequences for 68Ga-PSMA-11 PET/MRI in evaluation of biochemically recurrent prostate cancer
Hybrid imaging with [68Ga]PSMA-11 PET-CT and PET-MRI in biochemically recurrent prostate cancer
Impact of PET acquisition durations on image quality and lesion detectability in whole-body 68Ga-PSMA PET-MRI
44Sc-PSMA-617 for radiotheragnostics in tandem with 177Lu-PSMA-617—preclinical investigations in comparison with 68Ga-PSMA-11 and 68Ga-PSMA-617
68Ga-PSMA and 68Ga-FAPI radioligands in the diagnosis of tumors
Supervised machine learning enables non-invasive lesion characterization in primary prostate cancer with [68Ga]Ga-PSMA-11 PET/MRI
Multiparametric dynamic whole-body PSMA PET/CT using [68Ga]Ga-PSMA-11 and [18F]PSMA-1007
Cyclotron-based production of 68Ga, [68Ga]GaCl3, and [68Ga]Ga-PSMA-11 from a liquid target
Gross tumor volume delineation in primary prostate cancer on 18F-PSMA-1007 PET/MRI and 68Ga-PSMA-11 PET/MRI
Evaluation of prostatic lesions by simultaneous [68Ga]Ga-PSMA-11 PET/MRI
Recurrent prostate cancer: combined role for MRI and PSMA-PET in 68Ga-PSMA-11 PET/MRI
68Ga-PSMA-11 PET/MRI: determining ideal acquisition times to reduce noise and increase image quality
Optimal MRI sequences for 68Ga-PSMA-11 PET/MRI in evaluation of biochemically recurrent prostate cancer
Hybrid imaging with [68Ga]PSMA-11 PET-CT and PET-MRI in biochemically recurrent prostate cancer
Impact of PET acquisition durations on image quality and lesion detectability in whole-body 68Ga-PSMA PET-MRI
44Sc-PSMA-617 for radiotheragnostics in tandem with 177Lu-PSMA-617—preclinical investigations in comparison with 68Ga-PSMA-11 and 68Ga-PSMA-617
68Ga-PSMA and 68Ga-FAPI radioligands in the diagnosis of tumors
Supervised machine learning enables non-invasive lesion characterization in primary prostate cancer with [68Ga]Ga-PSMA-11 PET/MRI
Multiparametric dynamic whole-body PSMA PET/CT using [68Ga]Ga-PSMA-11 and [18F]PSMA-1007
Cyclotron-based production of 68Ga, [68Ga]GaCl3, and [68Ga]Ga-PSMA-11 from a liquid target
Gross tumor volume delineation in primary prostate cancer on 18F-PSMA-1007 PET/MRI and 68Ga-PSMA-11 PET/MRI
Evaluation of prostatic lesions by simultaneous [68Ga]Ga-PSMA-11 PET/MRI
Recurrent prostate cancer: combined role for MRI and PSMA-PET in 68Ga-PSMA-11 PET/MRI
68Ga-PSMA-11 PET/MRI: determining ideal acquisition times to reduce noise and increase image quality
Optimal MRI sequences for 68Ga-PSMA-11 PET/MRI in evaluation of biochemically recurrent prostate cancer
Hybrid imaging with [68Ga]PSMA-11 PET-CT and PET-MRI in biochemically recurrent prostate cancer
Impact of PET acquisition durations on image quality and lesion detectability in whole-body 68Ga-PSMA PET-MRI
44Sc-PSMA-617 for radiotheragnostics in tandem with 177Lu-PSMA-617—preclinical investigations in comparison with 68Ga-PSMA-11 and 68Ga-PSMA-617
68Ga-PSMA and 68Ga-FAPI radioligands in the diagnosis of tumors
Supervised machine learning enables non-invasive lesion characterization in primary prostate cancer with [68Ga]Ga-PSMA-11 PET/MRI
Multiparametric dynamic whole-body PSMA PET/CT using [68Ga]Ga-PSMA-11 and [18F]PSMA-1007